COLLABORATION, EXCLUSIVE LICENSE, AND COMPANION DIAGNOSTIC AGREEMENT by and between Merck Sharp & Dohme Research GmbH and ENDOCYTE, INC.Diagnostic Agreement • August 13th, 2012 • Endocyte Inc • Pharmaceutical preparations • New York
This Collaboration, Exclusive License and Companion Diagnostic Agreement (this “Agreement”) is effective as of April 13, 2012, (the “Execution Date”) and is entered into by and between Merck Sharp & Dohme Research GmbH, a corporation organized and existing under the laws of Switzerland (“Merck”), and ENDOCYTE, INC., a corporation organized and existing under the laws of Delaware (“Endocyte”).
